These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3966920)

  • 1. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
    Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
    Aoki T; Sebolt J; Weber G
    Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin.
    Aoki T; Oya H
    Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
    Aoki T; Oya H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
    Leube K; Keppler DO
    Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
    Elliott WL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine- and N-acetyl-L-glutamate-dependent carbamoyl phosphate synthetase from Micropterus salmoides. Purification, properties, and inhibition by glutamine analogs.
    Casey CA; Anderson PM
    J Biol Chem; 1983 Jul; 258(14):8723-32. PubMed ID: 6602805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW; Jayaram HN; Cooney DA
    Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues.
    Aoki T; Morris HP; Weber G
    J Biol Chem; 1982 Jan; 257(1):432-8. PubMed ID: 7053379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver.
    Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W
    Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
    Nichols KE; Chitneni SR; Moore JO; Weinberg JB
    Blood; 1989 Oct; 74(5):1728-37. PubMed ID: 2790198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organisation and sequence determination of glutamine-dependent carbamoyl phosphate synthetase II in Toxoplasma gondii.
    Fox BA; Bzik DJ
    Int J Parasitol; 2003 Jan; 33(1):89-96. PubMed ID: 12547350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin.
    Miles BW; Thoden JB; Holden HM; Raushel FM
    J Biol Chem; 2002 Feb; 277(6):4368-73. PubMed ID: 11729189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiometric enzyme-inhibition technique for measuring acivicin in plasma.
    Jayaram HN; Kensler TW; Ardalan B
    Cancer Treat Rep; 1981; 65(5-6):491-4. PubMed ID: 7237469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.